LANCET:一分钟了解扩张型心肌病

2017-02-14 MedSci MedSci原创

扩张型心肌病的定义为存在左心室扩张和收缩功能障碍。高达35%的扩张型心肌病存在编码细胞骨架、肌节和核包膜蛋白的基因突变。获得性扩张型心肌病的原因包括心肌炎和接触酒精、药物和毒素,以及代谢和内分泌紊乱。其最常见的症状有充血性心力衰竭,此外,还包括循环衰竭、心律失常和血栓栓塞事件。继发性神经激素变化有助于逆转重塑和持续的心肌细胞损伤。射血分数极低或严重舒张功能障碍患者的预后是最差的。慢性心力衰竭的治疗

扩张型心肌病的定义为存在左心室扩张和收缩功能障碍。


高达35%的扩张型心肌病存在编码细胞骨架、肌节和核包膜蛋白的基因突变。

获得性扩张型心肌病的原因包括心肌炎和接触酒精、药物和毒素,以及代谢和内分泌紊乱。

其最常见的症状有充血性心力衰竭,此外,还包括循环衰竭、心律失常和血栓栓塞事件。

继发性神经激素变化有助于逆转重塑和持续的心肌细胞损伤。

射血分数极低或严重舒张功能障碍患者的预后是最差的。

慢性心力衰竭的治疗包括改善生存质量和减少住院,换句话说,即使用血管紧张素转化酶抑制剂和β阻断剂。

其他干预包括入选多学科心力衰竭管理,以及使用治疗心律失常和预防猝死的装置。

对药物难治的患者可能从机械循环支持和心脏移植中获益。

目前,正在研究发生临床症状以前的治疗和干细胞治疗的潜在作用。

原始出处:
Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017 Feb 9. pii: S0140-6736(16)31713-5. 

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1828770, encodeId=f80d1828e70d7, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Mar 21 22:10:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684678, encodeId=848916846e89e, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Wed May 17 20:10:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176617, encodeId=1d3f1e6617ae, content=最新研究进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Feb 17 12:40:10 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622252, encodeId=63ad162225248, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Feb 16 08:10:00 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176179, encodeId=a85d1e617997, content=无敌学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Wed Feb 15 00:27:46 CST 2017, time=2017-02-15, status=1, ipAttribution=)]
    2017-03-21 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1828770, encodeId=f80d1828e70d7, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Mar 21 22:10:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684678, encodeId=848916846e89e, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Wed May 17 20:10:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176617, encodeId=1d3f1e6617ae, content=最新研究进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Feb 17 12:40:10 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622252, encodeId=63ad162225248, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Feb 16 08:10:00 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176179, encodeId=a85d1e617997, content=无敌学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Wed Feb 15 00:27:46 CST 2017, time=2017-02-15, status=1, ipAttribution=)]
    2017-05-17 lsj637
  3. [GetPortalCommentsPageByObjectIdResponse(id=1828770, encodeId=f80d1828e70d7, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Mar 21 22:10:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684678, encodeId=848916846e89e, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Wed May 17 20:10:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176617, encodeId=1d3f1e6617ae, content=最新研究进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Feb 17 12:40:10 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622252, encodeId=63ad162225248, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Feb 16 08:10:00 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176179, encodeId=a85d1e617997, content=无敌学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Wed Feb 15 00:27:46 CST 2017, time=2017-02-15, status=1, ipAttribution=)]
    2017-02-17 天涯183

    最新研究进展

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1828770, encodeId=f80d1828e70d7, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Mar 21 22:10:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684678, encodeId=848916846e89e, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Wed May 17 20:10:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176617, encodeId=1d3f1e6617ae, content=最新研究进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Feb 17 12:40:10 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622252, encodeId=63ad162225248, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Feb 16 08:10:00 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176179, encodeId=a85d1e617997, content=无敌学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Wed Feb 15 00:27:46 CST 2017, time=2017-02-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1828770, encodeId=f80d1828e70d7, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Mar 21 22:10:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684678, encodeId=848916846e89e, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Wed May 17 20:10:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176617, encodeId=1d3f1e6617ae, content=最新研究进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Feb 17 12:40:10 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622252, encodeId=63ad162225248, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Feb 16 08:10:00 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176179, encodeId=a85d1e617997, content=无敌学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Wed Feb 15 00:27:46 CST 2017, time=2017-02-15, status=1, ipAttribution=)]
    2017-02-15 jihuaijun1112

    无敌学习

    0

相关资讯

JAMA:心肌纤维化是扩张型心肌病患者发生心源性猝死的独立预测因素

扩张型心肌病(DCM)是临床上常见的原发性心肌病,其主要表现为无明显冠状动脉狭窄的情况下出现心室腔的扩大,该病的总体预后不佳,尽管经过积极药物治疗,5年生存率仍小于80%,主要死亡原因为收缩性心力衰竭和心源性猝死。近来年,随着植入式转复除颤器(ICD)的问世,许多DCM患者避免了SCD的发生,然而由于ICD的价格昂贵,多数患者无法承受经济压力,为提高性价比,对DCM患者进行危险分层,识别高危患者具

NEJM:扩张型心肌病与TTN基因突变有关

近日,由哈佛大学医学院Christine Seidman和Johathan Seidman哈佛医学院遗传学教授牵头的最新研究发现,18%的零散发生DCM和25%的家族性DCM是由TTN基因突变引起的。在2月16日的《新英格兰医学杂志》(New England Journal of Medicine)发表了研究报告指出,TTN是DCM的主要原因。 扩张型心肌病(dilated cardiomy

NEJM: 围产期心肌病与特发性扩张型心肌病存在相同的易感基因

围产期心肌病与扩张型心肌病存在一些相同的临床特点,扩张型心肌病是40多个基因突变所致,其中包括TTN——编码肌节的肌联蛋白的基因。

JACC:扩张型心肌病患者基因环境相互作用的预后意义

多因素发病导致扩张性心肌病(DCM),使得分层困难。最近MOGE(S)(形态功能,器官受累,遗传性或家族性,病因,分类阶段)解决了这个问题。本研究的目的是调查DCM患者MOGE(S)分类的适用性和预后相关性。本研究的参与者来自于荷兰的马斯特里赫特心肌病登记患者,并排除了缺血性,心脏瓣膜,高血压,和先天性心脏疾病的患者。所有其他患者进行了全面诊断工作,包括遗传评估和心内膜心肌活检。本研究共包括213

NEJM:TTN基因突变可能是扩张性心肌病病因有关

 DCM导致心脏虚弱、肥大,估计每年有160万美国人因此陷入心衰危险。几十年来,研究人员试图从基因角度寻求解释特发性扩张型心肌病(dilated cardiomyopathy,DCM)的答案,因为特发性扩张型心肌病的发生呈家族性。尽管研究人员一直在寻找它的基因原因,但多数病人的心脏病病因仍不清楚。 由哈佛大学医学院Christine Seidman和Johathan Seidma

JACC:阜外医院陆敏杰等发现扩张型心肌病患者多有脂肪沉积

特发性扩张型心肌病(DCM)是目前进行过心脏移植的年轻人心力衰竭最常见的原因,但人们对脂肪沉积在DCM中的临床价值了解甚少。阜外医院陆敏杰等人对此进行了研究,发现脂肪沉积现象在DCM患者中较为普遍,且与DCM诸多特征相关,研究结果近期发表于《美国心脏病学会杂志》。 研究利用水脂分离成像法,前瞻性探索了脂肪沉积在特发性扩张型心肌病(DCM)患者中的发生率,以及左心室(LV)脂肪沉积与心肌纤维化及心